United States Healthcare Equipment & Supplies

Haemonetics Corp (HAE)

Track

Track

Haemonetics Corp experienced insider activity most recently on November 10, 2025, when Mark W. Kroll executed a purchase of 1,400 shares. Prior to this, various officers engaged in multiple proposed or planned divestments throughout 2024 and mid-2025. These historical transactions reflect diverse individual portfolio management decisions rather than a singular unified trend.
Ticker: HAE Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Haemonetics Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.3
KROLL MARK W Non-Executive Director
Transaction date
Purchase
Price
473.71
Quantity 37,547 -22.0%
Value US$4,669,138
2.2
Llorens Josep Former Officer Officer
Transaction date
Proposed sale
Price
293.04
Quantity 73,438
Value US$4,144,593
3.0
Strong Stewart W Former Officer Officer
Transaction date
Proposed sale
Price
49.10
Quantity 62,131
Value US$1,841,284
3.0
Strong Stewart W Officer Officer
Transaction date
Proposed sale
Price
69.90
Quantity 7,705
Value US$538,580
3.0
Strong Stewart W Officer Officer
Transaction date
Proposed sale
Price
67.47
Quantity 2,835
Value US$191,277
2.2
Llorens Josep Officer Officer
Transaction date
Proposed sale
Price
69.37
Quantity 1,547
Value US$107,319
1.6
Lingamneni Anila Former Officer Officer
Transaction date
Proposed sale
Price
90.68
Quantity 6,238
Value US$565,692
3.0
Strong Stewart W President, Global Hospital Officer
Transaction date
Planned sale
Price
91.15
Quantity 4,312 -19.2%
Value US$393,039
3.0
Strong Stewart W Officer Officer
Transaction date
Proposed sale
Price
91.15
Quantity 4,312
Value US$393,039
1.6
Lingamneni Anila EVP, Chief Technology Officer Officer
Transaction date
Planned sale
Price
90.00
Quantity 79 -0.4%
Value US$7,110
1.6
Lingamneni Anila Officer Officer
Transaction date
Proposed sale
Price
90.00
Quantity 79
Value US$7,110
1.6
Lingamneni Anila EVP, Chief Technology Officer Officer
Transaction date
Planned sale
Price
90.00
Quantity 2,136 -9.1%
Value US$192,240
1.6
Lingamneni Anila Officer Officer
Transaction date
Proposed sale
Price
90.00
Quantity 2,136
Value US$192,240
3.0
Basil Michelle L Officer Officer
Transaction date
Proposed sale
Price
87.53
Quantity 12,990
Value US$1,137,015
3.0
Strong Stewart W Officer Officer
Transaction date
Proposed sale
Price
87.53
Quantity 8,857
Value US$775,253
3.0
Basil Michelle L EVP and General Counsel Officer
Transaction date
Planned sale
Price
88.57
Quantity 4,094 -11.6%
Value US$362,606
3.0
Basil Michelle L EVP and General Counsel Officer
Transaction date
Planned sale
Price
87.86
Quantity 8,896 -20.1%
Value US$781,603
3.0
Strong Stewart W President, Global Hospital Officer
Transaction date
Planned sale
Price
87.53
Quantity 8,857 -32.7%
Value US$775,253
3.0
Basil Michelle L EVP and General Counsel Officer
Transaction date
Planned sale
Price
95.08
Quantity 1,604 -4.9%
Value US$152,508
2.2
Llorens Josep EVP, Global Manufacturing Officer
Transaction date
Planned sale
Price
95.08
Quantity 987 -4.4%
Value US$93,844
3.0
Strong Stewart W President, Global Hospital Officer
Transaction date
Planned sale
Price
95.11
Quantity 686 -3.6%
Value US$65,245
3.0
Strong Stewart W Officer Officer
Transaction date
Proposed sale
Price
95.11
Quantity 686
Value US$65,245
3.0
Basil Michelle L Officer Officer
Transaction date
Proposed sale
Price
95.08
Quantity 1,604
Value US$152,508
2.2
Llorens Josep Officer Officer
Transaction date
Proposed sale
Price
95.08
Quantity 987
Value US$93,844
3.0
Basil Michelle L EVP and General Counsel Officer
Transaction date
Planned sale
Price
95.00
Quantity 1,073 -3.5%
Value US$101,935
2.2
Llorens Josep EVP, Global Manufacturing Officer
Transaction date
Planned sale
Price
94.82
Quantity 822 -4.8%
Value US$77,942
3.0
Basil Michelle L Officer Officer
Transaction date
Proposed sale
Price
95.00
Quantity 1,073
Value US$101,935
2.2
Llorens Josep Officer Officer
Transaction date
Proposed sale
Price
94.82
Quantity 822
Value US$77,942
2.2
Llorens Josep EVP, Global Manufacturing Officer
Transaction date
Planned sale
Price
96.14
Quantity 770 -4.3%
Value US$74,028
3.0
Basil Michelle L EVP and General Counsel Officer
Transaction date
Planned sale
Price
96.14
Quantity 985 -3.1%
Value US$94,698
3.0
Strong Stewart W President, Global Hospital Officer
Transaction date
Planned sale
Price
96.04
Quantity 733 -4.5%
Value US$70,397
2.2
Llorens Josep Officer Officer
Transaction date
Proposed sale
Price
96.14
Quantity 770
Value US$74,028
3.0
Strong Stewart W Officer Officer
Transaction date
Proposed sale
Price
96.04
Quantity 733
Value US$70,400
3.0
Basil Michelle L Officer Officer
Transaction date
Proposed sale
Price
96.14
Quantity 985
Value US$94,698
1.6
Lingamneni Anila EVP, Chief Technology Officer Officer
Transaction date
Planned sale
Price
95.00
Quantity 2,305 -15.8%
Value US$218,975
1.6
Lingamneni Anila Officer Officer
Transaction date
Proposed sale
Price
95.00
Quantity 2,305
Value US$218,975
3.0
Strong Stewart W President, Global Hospital Officer
Transaction date
Planned sale
Price
90.65
Quantity 228 -1.4%
Value US$20,668
3.0
Strong Stewart W Officer Officer
Transaction date
Proposed sale
Price
90.65
Quantity 228
Value US$20,668
1.6
Lingamneni Anila EVP, Chief Technology Officer Officer
Transaction date
Planned sale
Price
90.00
Quantity 2,305 -13.7%
Value US$207,450
1.6
Lingamneni Anila Officer Officer
Transaction date
Proposed sale
Price
90.00
Quantity 2,305
Value US$207,450
3.8
Dockendorff Charles J Non-Executive Director
Transaction date
Planned sale
Price
87.68
Quantity 10,215 -82.1%
Value US$895,651
3.8
Dockendorff Charles J Director Non-Executive Director
Transaction date
Proposed sale
Price
89.56
Quantity 10,215
Value US$914,855
2.2
Llorens Josep EVP, Global Manufacturing Officer
Transaction date
Planned sale
Price
90.00
Quantity 4,928 -21.1%
Value US$443,520
2.2
Llorens Josep Officer Officer
Transaction date
Proposed sale
Price
90.00
Quantity 4,928
Value US$443,520
3.0
Strong Stewart W President, Global Hospital Officer
Transaction date
Sale
Price
88.04
Quantity 2,538 -13.4%
Value US$223,446
3.0
Strong Stewart W Officer Officer
Transaction date
Proposed sale
Price
88.04
Quantity 2,538
Value US$223,451
1.6
Lingamneni Anila EVP, Chief Technology Officer Officer
Transaction date
Sale
Price
83.33
Quantity 2,304 -12.1%
Value US$191,992
1.6
Lingamneni Anila Officer Officer
Transaction date
Proposed sale
Price
83.33
Quantity 2,304
Value US$191,992
2.2
Llorens Josep EVP, Global Manufacturing Officer
Transaction date
Planned sale
Price
90.00
Quantity 2,391 -12.2%
Value US$215,190
3.0
Strong Stewart W President, Global Hospital Officer
Transaction date
Sale
Price
80.39
Quantity 75 -0.5%
Value US$6,029
3.0
Basil Michelle L EVP and General Counsel Officer
Transaction date
Sale
Price
80.39
Quantity 180 -0.6%
Value US$14,470
1.6
Miller Laurie A. SVP, Human Resources Officer
Transaction date
Sale
Price
76.25
Quantity 212 -1.6%
Value US$16,165
3.0
Basil Michelle L EVP and General Counsel Officer
Transaction date
Planned sale
Price
78.36
Quantity 11,448 -26.0%
Value US$897,065
3.0
Basil Michelle L EVP and General Counsel Officer
Transaction date
Planned sale
Price
78.50
Quantity 6,029 -14.6%
Value US$473,276
3.0
Basil Michelle L EVP and General Counsel Officer
Transaction date
Planned sale
Price
77.76
Quantity 27,769 -40.1%
Value US$2,159,317
2.2
Llorens Josep EVP, Global Manufacturing Officer
Transaction date
Sale
Price
73.78
Quantity 101 -0.6%
Value US$7,452
2.3
KROLL MARK W Non-Executive Director
Transaction date
Sale
Price
73.71
Quantity 8,016 -33.1%
Value US$590,859
1.6
Miller Laurie A. SVP, Human Resources Officer
Transaction date
Sale
Price
66.18
Quantity 42 -0.3%
Value US$2,780
1.6
Miller Laurie A. SVP, Human Resources Officer
Transaction date
Sale
Price
62.60
Quantity 30 -0.2%
Value US$1,878
2.9
Simon, Christopher President & CEO Executive Director
Transaction date
Sale
Price
62.60
Quantity 1,148 -0.5%
Value US$71,865
3.0
Basil Michelle L EVP and General Counsel Officer
Transaction date
Sale
Price
62.60
Quantity 277 -0.7%
Value US$17,340
4.0
Goldstein Dan VP, Corporate Controller Officer
Transaction date
Sale
Price
62.60
Quantity 42 -0.9%
Value US$2,629
1.6
Miller Laurie A. SVP, Human Resources Officer
Transaction date
Sale
Price
62.69
Quantity 198 -1.5%
Value US$12,413
4.0
Goldstein Dan VP, Corporate Controller Officer
Transaction date
Sale
Price
62.69
Quantity 249 -5.3%
Value US$15,610
4.0
Goldstein Dan VP, Corporate Controller Officer
Transaction date
Sale
Price
59.10
Quantity 134 -2.8%
Value US$7,919
1.6
Miller Laurie A. SVP, Human Resources Officer
Transaction date
Sale
Price
59.10
Quantity 91 -0.7%
Value US$5,378
1.6
Lingamneni Anila EVP, Chief Technology Officer Officer
Transaction date
Sale
Price
59.10
Quantity 1,384 -7.4%
Value US$81,794
2.9
Simon, Christopher President & CEO Executive Director
Transaction date
Sale
Price
59.10
Quantity 2,496 -1.1%
Value US$147,514
3.0
Strong Stewart W President, Global Hospital Officer
Transaction date
Sale
Price
59.10
Quantity 1,084 -6.4%
Value US$64,064
3.0
Basil Michelle L EVP and General Counsel Officer
Transaction date
Sale
Price
59.10
Quantity 3,258 -7.4%
Value US$192,548
2.2
Llorens Josep EVP, Global Manufacturing Officer
Transaction date
Sale
Price
59.10
Quantity 1,418 -7.6%
Value US$83,804
2.9
Simon, Christopher President & CEO Executive Director
Transaction date
Planned sale
Price
56.10
Quantity 832 -0.4%
Value US$46,675
4.0
Goldstein Dan VP, Corporate Controller Officer
Transaction date
Sale
Price
56.10
Quantity 50 -1.2%
Value US$2,805
3.0
Basil Michelle L EVP and General Counsel Officer
Transaction date
Sale
Price
56.10
Quantity 196 -0.5%
Value US$10,996
1.6
Miller Laurie A. SVP, Human Resources Officer
Transaction date
Planned sale
Price
56.10
Quantity 31 -0.3%
Value US$1,739
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-12 2025-11-10 B Purchase
2.3
KROLL MARK W
Non-Executive Director
37,547 -22.0%
473.71
US$4,669,138 		37,547 -22.0% 473.71 US$4,669,138
2025-06-26 2025-06-26 PrS Proposed sale
2.2
Llorens Josep

Former Officer

Officer
73,438
293.04
US$4,144,593 		73,438 293.04 US$4,144,593
2025-06-12 2025-06-12 PrS Proposed sale
3.0
Strong Stewart W

Former Officer

Officer
62,131
49.10
US$1,841,284 		62,131 49.10 US$1,841,284
2025-06-04 2025-06-04 PrS Proposed sale
3.0
Strong Stewart W

Officer

Officer
7,705
69.90
US$538,580 		7,705 69.90 US$538,580
2025-06-02 2025-06-02 PrS Proposed sale
3.0
Strong Stewart W

Officer

Officer
2,835
67.47
US$191,277 		2,835 67.47 US$191,277
2025-05-19 2025-05-19 PrS Proposed sale
2.2
Llorens Josep

Officer

Officer
1,547
69.37
US$107,319 		1,547 69.37 US$107,319
2024-11-12 2024-11-11 PrS Proposed sale
1.6
Lingamneni Anila

Former Officer

Officer
6,238
90.68
US$565,692 		6,238 90.68 US$565,692
2024-07-29 2024-07-26 PlS Planned sale
3.0
Strong Stewart W

President, Global Hospital

Officer
4,312 -19.2%
91.15
US$393,039 		4,312 -19.2% 91.15 US$393,039
2024-07-26 2024-07-26 PrS Proposed sale
3.0
Strong Stewart W

Officer

Officer
4,312
91.15
US$393,039 		4,312 91.15 US$393,039
2024-07-15 2024-07-12 PlS Planned sale
1.6
Lingamneni Anila

EVP, Chief Technology Officer

Officer
79 -0.4%
90.00
US$7,110 		79 -0.4% 90.00 US$7,110
2024-07-12 2024-07-12 PrS Proposed sale
1.6
Lingamneni Anila

Officer

Officer
79
90.00
US$7,110 		79 90.00 US$7,110
2024-07-15 2024-07-11 PlS Planned sale
1.6
Lingamneni Anila

EVP, Chief Technology Officer

Officer
2,136 -9.1%
90.00
US$192,240 		2,136 -9.1% 90.00 US$192,240
2024-07-11 2024-07-11 PrS Proposed sale
1.6
Lingamneni Anila

Officer

Officer
2,136
90.00
US$192,240 		2,136 90.00 US$192,240
2024-05-29 2024-05-29 PrS Proposed sale
3.0
Basil Michelle L

Officer

Officer
12,990
87.53
US$1,137,015 		12,990 87.53 US$1,137,015
2024-05-29 2024-05-29 PrS Proposed sale
3.0
Strong Stewart W

Officer

Officer
8,857
87.53
US$775,253 		8,857 87.53 US$775,253
2024-05-29 2024-05-29 PlS Planned sale
3.0
Basil Michelle L

EVP and General Counsel

Officer
4,094 -11.6%
88.57
US$362,606 		4,094 -11.6% 88.57 US$362,606
2024-05-29 2024-05-29 PlS Planned sale
3.0
Basil Michelle L

EVP and General Counsel

Officer
8,896 -20.1%
87.86
US$781,603 		8,896 -20.1% 87.86 US$781,603
2024-05-29 2024-05-29 PlS Planned sale
3.0
Strong Stewart W

President, Global Hospital

Officer
8,857 -32.7%
87.53
US$775,253 		8,857 -32.7% 87.53 US$775,253
2024-05-21 2024-05-20 PlS Planned sale
3.0
Basil Michelle L

EVP and General Counsel

Officer
1,604 -4.9%
95.08
US$152,508 		1,604 -4.9% 95.08 US$152,508
2024-05-21 2024-05-20 PlS Planned sale
2.2
Llorens Josep

EVP, Global Manufacturing

Officer
987 -4.4%
95.08
US$93,844 		987 -4.4% 95.08 US$93,844
2024-05-21 2024-05-20 PlS Planned sale
3.0
Strong Stewart W

President, Global Hospital

Officer
686 -3.6%
95.11
US$65,245 		686 -3.6% 95.11 US$65,245
2024-05-20 2024-05-20 PrS Proposed sale
3.0
Strong Stewart W

Officer

Officer
686
95.11
US$65,245 		686 95.11 US$65,245
2024-05-20 2024-05-20 PrS Proposed sale
3.0
Basil Michelle L

Officer

Officer
1,604
95.08
US$152,508 		1,604 95.08 US$152,508
2024-05-20 2024-05-20 PrS Proposed sale
2.2
Llorens Josep

Officer

Officer
987
95.08
US$93,844 		987 95.08 US$93,844
2024-05-21 2024-05-17 PlS Planned sale
3.0
Basil Michelle L

EVP and General Counsel

Officer
1,073 -3.5%
95.00
US$101,935 		1,073 -3.5% 95.00 US$101,935
2024-05-21 2024-05-17 PlS Planned sale
2.2
Llorens Josep

EVP, Global Manufacturing

Officer
822 -4.8%
94.82
US$77,942 		822 -4.8% 94.82 US$77,942
2024-05-17 2024-05-17 PrS Proposed sale
3.0
Basil Michelle L

Officer

Officer
1,073
95.00
US$101,935 		1,073 95.00 US$101,935
2024-05-17 2024-05-17 PrS Proposed sale
2.2
Llorens Josep

Officer

Officer
822
94.82
US$77,942 		822 94.82 US$77,942
2024-05-17 2024-05-16 PlS Planned sale
2.2
Llorens Josep

EVP, Global Manufacturing

Officer
770 -4.3%
96.14
US$74,028 		770 -4.3% 96.14 US$74,028
2024-05-17 2024-05-16 PlS Planned sale
3.0
Basil Michelle L

EVP and General Counsel

Officer
985 -3.1%
96.14
US$94,698 		985 -3.1% 96.14 US$94,698
2024-05-17 2024-05-16 PlS Planned sale
3.0
Strong Stewart W

President, Global Hospital

Officer
733 -4.5%
96.04
US$70,397 		733 -4.5% 96.04 US$70,397
2024-05-16 2024-05-16 PrS Proposed sale
2.2
Llorens Josep

Officer

Officer
770
96.14
US$74,028 		770 96.14 US$74,028
2024-05-16 2024-05-16 PrS Proposed sale
3.0
Strong Stewart W

Officer

Officer
733
96.04
US$70,400 		733 96.04 US$70,400
2024-05-16 2024-05-16 PrS Proposed sale
3.0
Basil Michelle L

Officer

Officer
985
96.14
US$94,698 		985 96.14 US$94,698
2024-05-08 2024-05-06 PlS Planned sale
1.6
Lingamneni Anila

EVP, Chief Technology Officer

Officer
2,305 -15.8%
95.00
US$218,975 		2,305 -15.8% 95.00 US$218,975
2024-05-06 2024-05-06 PrS Proposed sale
1.6
Lingamneni Anila

Officer

Officer
2,305
95.00
US$218,975 		2,305 95.00 US$218,975
2023-09-13 2023-09-12 PlS Planned sale
3.0
Strong Stewart W

President, Global Hospital

Officer
228 -1.4%
90.65
US$20,668 		228 -1.4% 90.65 US$20,668
2023-09-12 2023-09-12 PrS Proposed sale
3.0
Strong Stewart W

Officer

Officer
228
90.65
US$20,668 		228 90.65 US$20,668
2023-09-13 2023-09-11 PlS Planned sale
1.6
Lingamneni Anila

EVP, Chief Technology Officer

Officer
2,305 -13.7%
90.00
US$207,450 		2,305 -13.7% 90.00 US$207,450
2023-09-11 2023-09-11 PrS Proposed sale
1.6
Lingamneni Anila

Officer

Officer
2,305
90.00
US$207,450 		2,305 90.00 US$207,450
2023-09-07 2023-09-05 PlS Planned sale
3.8
Dockendorff Charles J
Non-Executive Director
10,215 -82.1%
87.68
US$895,651 		10,215 -82.1% 87.68 US$895,651
2023-09-05 2023-09-05 PrS Proposed sale
3.8
Dockendorff Charles J

Director

Non-Executive Director
10,215
89.56
US$914,855 		10,215 89.56 US$914,855
2023-07-20 2023-07-18 PlS Planned sale
2.2
Llorens Josep

EVP, Global Manufacturing

Officer
4,928 -21.1%
90.00
US$443,520 		4,928 -21.1% 90.00 US$443,520
2023-07-18 2023-07-18 PrS Proposed sale
2.2
Llorens Josep

Officer

Officer
4,928
90.00
US$443,520 		4,928 90.00 US$443,520
2023-06-09 2023-06-07 S Sale
3.0
Strong Stewart W

President, Global Hospital

Officer
2,538 -13.4%
88.04
US$223,446 		2,538 -13.4% 88.04 US$223,446
2023-06-07 2023-06-07 PrS Proposed sale
3.0
Strong Stewart W

Officer

Officer
2,538
88.04
US$223,451 		2,538 88.04 US$223,451
2023-06-01 2023-05-30 S Sale
1.6
Lingamneni Anila

EVP, Chief Technology Officer

Officer
2,304 -12.1%
83.33
US$191,992 		2,304 -12.1% 83.33 US$191,992
2023-05-30 2023-05-30 PrS Proposed sale
1.6
Lingamneni Anila

Officer

Officer
2,304
83.33
US$191,992 		2,304 83.33 US$191,992
2023-01-25 2023-01-23 PlS Planned sale
2.2
Llorens Josep

EVP, Global Manufacturing

Officer
2,391 -12.2%
90.00
US$215,190 		2,391 -12.2% 90.00 US$215,190
2022-10-26 2022-10-24 S Sale
3.0
Strong Stewart W

President, Global Hospital

Officer
75 -0.5%
80.39
US$6,029 		75 -0.5% 80.39 US$6,029
2022-10-26 2022-10-24 S Sale
3.0
Basil Michelle L

EVP and General Counsel

Officer
180 -0.6%
80.39
US$14,470 		180 -0.6% 80.39 US$14,470
2022-09-21 2022-09-19 S Sale
1.6
Miller Laurie A.

SVP, Human Resources

Officer
212 -1.6%
76.25
US$16,165 		212 -1.6% 76.25 US$16,165
2022-09-21 2022-09-19 PlS Planned sale
3.0
Basil Michelle L

EVP and General Counsel

Officer
11,448 -26.0%
78.36
US$897,065 		11,448 -26.0% 78.36 US$897,065
2022-09-19 2022-09-15 PlS Planned sale
3.0
Basil Michelle L

EVP and General Counsel

Officer
6,029 -14.6%
78.50
US$473,276 		6,029 -14.6% 78.50 US$473,276
2022-09-19 2022-09-15 PlS Planned sale
3.0
Basil Michelle L

EVP and General Counsel

Officer
27,769 -40.1%
77.76
US$2,159,317 		27,769 -40.1% 77.76 US$2,159,317
2022-09-07 2022-09-06 S Sale
2.2
Llorens Josep

EVP, Global Manufacturing

Officer
101 -0.6%
73.78
US$7,452 		101 -0.6% 73.78 US$7,452
2022-08-16 2022-08-15 S Sale
2.3
KROLL MARK W
Non-Executive Director
8,016 -33.1%
73.71
US$590,859 		8,016 -33.1% 73.71 US$590,859
2022-07-06 2022-07-05 S Sale
1.6
Miller Laurie A.

SVP, Human Resources

Officer
42 -0.3%
66.18
US$2,780 		42 -0.3% 66.18 US$2,780
2022-06-15 2022-06-13 S Sale
1.6
Miller Laurie A.

SVP, Human Resources

Officer
30 -0.2%
62.60
US$1,878 		30 -0.2% 62.60 US$1,878
2022-06-15 2022-06-13 S Sale
2.9
Simon, Christopher

President & CEO

Executive Director
1,148 -0.5%
62.60
US$71,865 		1,148 -0.5% 62.60 US$71,865
2022-06-15 2022-06-13 S Sale
3.0
Basil Michelle L

EVP and General Counsel

Officer
277 -0.7%
62.60
US$17,340 		277 -0.7% 62.60 US$17,340
2022-06-15 2022-06-13 S Sale
4.0
Goldstein Dan

VP, Corporate Controller

Officer
42 -0.9%
62.60
US$2,629 		42 -0.9% 62.60 US$2,629
2022-06-06 2022-06-02 S Sale
1.6
Miller Laurie A.

SVP, Human Resources

Officer
198 -1.5%
62.69
US$12,413 		198 -1.5% 62.69 US$12,413
2022-06-06 2022-06-02 S Sale
4.0
Goldstein Dan

VP, Corporate Controller

Officer
249 -5.3%
62.69
US$15,610 		249 -5.3% 62.69 US$15,610
2022-05-23 2022-05-19 S Sale
4.0
Goldstein Dan

VP, Corporate Controller

Officer
134 -2.8%
59.10
US$7,919 		134 -2.8% 59.10 US$7,919
2022-05-23 2022-05-19 S Sale
1.6
Miller Laurie A.

SVP, Human Resources

Officer
91 -0.7%
59.10
US$5,378 		91 -0.7% 59.10 US$5,378
2022-05-23 2022-05-19 S Sale
1.6
Lingamneni Anila

EVP, Chief Technology Officer

Officer
1,384 -7.4%
59.10
US$81,794 		1,384 -7.4% 59.10 US$81,794
2022-05-23 2022-05-19 S Sale
2.9
Simon, Christopher

President & CEO

Executive Director
2,496 -1.1%
59.10
US$147,514 		2,496 -1.1% 59.10 US$147,514
2022-05-23 2022-05-19 S Sale
3.0
Strong Stewart W

President, Global Hospital

Officer
1,084 -6.4%
59.10
US$64,064 		1,084 -6.4% 59.10 US$64,064
2022-05-23 2022-05-19 S Sale
3.0
Basil Michelle L

EVP and General Counsel

Officer
3,258 -7.4%
59.10
US$192,548 		3,258 -7.4% 59.10 US$192,548
2022-05-23 2022-05-19 S Sale
2.2
Llorens Josep

EVP, Global Manufacturing

Officer
1,418 -7.6%
59.10
US$83,804 		1,418 -7.6% 59.10 US$83,804
2022-05-18 2022-05-16 PlS Planned sale
2.9
Simon, Christopher

President & CEO

Executive Director
832 -0.4%
56.10
US$46,675 		832 -0.4% 56.10 US$46,675
2022-05-18 2022-05-16 S Sale
4.0
Goldstein Dan

VP, Corporate Controller

Officer
50 -1.2%
56.10
US$2,805 		50 -1.2% 56.10 US$2,805
2022-05-18 2022-05-16 S Sale
3.0
Basil Michelle L

EVP and General Counsel

Officer
196 -0.5%
56.10
US$10,996 		196 -0.5% 56.10 US$10,996
2022-05-18 2022-05-16 PlS Planned sale
1.6
Miller Laurie A.

SVP, Human Resources

Officer
31 -0.3%
56.10
US$1,739 		31 -0.3% 56.10 US$1,739
Explore more

More insider trading research around Haemonetics Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America